Bitcoin (btc)$77,465.00↑ 0.58%
Ethereum (eth)$2,252.77↑ 0.74%
Tether (usdt)$0.999537↑ 0.05%
BNB (bnb)$702.64↑ 0.26%
XRP (xrp)$1.25↓ 0.06%
USDC (usdc)$1.00↑ 0.03%
Solana (sol)$95.49↓ 0.41%
TRON (trx)$0.302124↓ 8.43%
Figure Heloc (figr_heloc)$1.064↑ 2.71%
Zcash (zec)$1,246.19↓ 0.12%
Hyperliquid (hype)$87.58↓ 1.68%
Dogecoin (doge)$0.075579↓ 0.14%
Monero (xmr)$598.11↑ 1.78%
USDS (usds)$1.001↑ 0.00%
Chainlink (link)$11.73↑ 3.22%
Bitcoin (btc)$77,465.00↑ 0.58%
Ethereum (eth)$2,252.77↑ 0.74%
Tether (usdt)$0.999537↑ 0.05%
BNB (bnb)$702.64↑ 0.26%
XRP (xrp)$1.25↓ 0.06%
USDC (usdc)$1.00↑ 0.03%
Solana (sol)$95.49↓ 0.41%
TRON (trx)$0.302124↓ 8.43%
Figure Heloc (figr_heloc)$1.064↑ 2.71%
Zcash (zec)$1,246.19↓ 0.12%
Hyperliquid (hype)$87.58↓ 1.68%
Dogecoin (doge)$0.075579↓ 0.14%
Monero (xmr)$598.11↑ 1.78%
USDS (usds)$1.001↑ 0.00%
Chainlink (link)$11.73↑ 3.22%

Ten63 Therapeutics Announces Collaboration with Boehringer Ingelheim for Drug Discovery – Draper Decentralized – 5.31.24

Published May 31, 2024

Ten63 Therapeutics, a biotechnology company specializing in advanced AI and physics-based models to tackle undruggable diseases, has partnered with Boehringer Ingelheim for multi-target drug discovery. This collaboration aims to develop new therapeutic molecules for diseases that conventional methods have not been able to treat, addressing significant unmet patient needs.